Referral Time for Diabetic Retinopathy Screening and Impact on the Visual Acuity of Patients in a Tertiary Hospital Timely Referral for DR Screening: Impact on Visual Acuity in a Tertiary Hospital
Article Sidebar
Main Article Content
Abstract
OBJECTIVE: To evaluate the referral time for the screening of diabetic retinopathy (DR) from the initial diagnosis of diabetes to retinal examination. We also compared visual results among groups screened at various duration of referral time.
METHODS: This cross-sectional study was conducted retrospectively from medical records for the poorer-seeing eyes of 100 patients with type 2 diabetes from January 2021 to December 2022 at the tertiary eye center. Patients were classified based on the time duration from the initial diagnosis of diabetes to retinal examination or imaging. Visual acuity (VA) and DR stages categorized by the period of referral time were compared among each group.
RESULTS: Seventy-five patients (75%) took > 2 months from the first diagnosis of diabetes to DR screening performed by an ophthalmologist. Twenty-three patients (23%) were diagnosed with DR at the first ophthalmic visit; among these, 16 had a referral time of > 2 months. Twelve patients were diagnosed with vision-threatening DR; six of these had diabetic macular edema. The receiver operating characteristic (ROC) curve analysis indicates that patients receiving ophthalmic examination within 91 days from the diagnosis of diabetes likely maintain a best-corrected VA of ≥ 20/50. This recommended period of referral time yielded an area under the ROC curve, sensitivity, and specificity of 70.63%, 61.90%, and 83.33%, respectively.
CONCLUSION: In clinical practice, a prolonged period for the first DR screening is relatively common and may result in more patients with vision-threatening DR. Proactive and systematic work should be undertaken to create patient awareness on the importance of detection of asymptomatic and early-stage DR to prevent irreversible visual loss.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Puangmee N, Kumteam K, Prakhunhungsit S. The prevalence and risk factors of diabetic retinopathy in type 2 diabetes mellitus patients in the eye clinic, Siriraj hospital. Thammasat Med J 2017;17(3):336-45.
Jeong IS, Kang CM. Time to diagnosis and treatment of diabetes mellitus among Korean adults with hyperglycemia: using a community-based cohort study. Int J Environ Res Public Health 2022;19(19):12090.
International Diabetes Federation. IDF diabetes Atlas, 10th edition [internet]. 2021 [cited 2023 Jul 1]. Available from:https://diabetesatlas.org/idfawp /resourcefiles/2021/07/IDF_Atlas_10th_Edition_2021.pdf
World Health Organization. Global report on diabetes. WHO report [internet]. 2016 [cited 2023 Jul 2]. Available from: https://www.who.int/publications/i/item/9789241565257.pdf
Aekplakorn W, Chariyalertsak S, Kessomboon P, Assanangkornchai S, Taneepanichskul S, Putwatana P. Prevalence of diabetes and relationship with socioeconomic status in the Thai population: national health examination survey, 2004-2014. J Diabetes Res 2018;2018:1654530.
Boontakanon J. Prevalence and factors associated with diabetic retinopathy type 2 diabetes mellitus in primary care unit at Kasetsomboon hospital. Med J Srisaket Surin Buriram Hosp 2022;37(2):341-51.
Chua J, Lim CXY, Wong TY, Sabanayagam C. Diabetic retinopathy in the Asia-Pacific. Asia Pac J Ophthalmol (Phila) 2018;7(1):3-16.
Kongtham T. Prevalence and factors associated with diabetic retinopathy in type 2: diabetes mellitus patients at Mae Hong Son province. Med J Srisaket Surin Buriram Hosp 2020;35(1):13-25.
Mahgoub S. The impact of delay in diabetic patient’s referral for diabetic retinopathy screening on the level of retinopathy detected in adult Sudanese diabetic Sudanese patients. Al-Basar Int J Ophthalmol 2017;4(2):49-53.
de Fine Olivarius N, Siersma V, Almind GJ, Nielsen NV. Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6-year follow up study. BMC Public Health 2011;11:80.
Das T, Takkar B, Sivaprasad S, Thanksphon T, Taylor H, Wiedemann P, et al. Recently updated global diabetic retinopathy screening guidelines: commonalities, differences, and future possibilities. Eye (Lond) 2021;35(10):2685-98.
Diabetes Association of Thailand under The Patronage of Her Royal Highness Princess Maha Chakri Sirindhorn. Clinical practice guideline for diabetes [internet]. 2023 [cited 30 Sep 2024]. Available from: https://www.dmthai.org/new/index.php/sara-khwam-ru/bukhlakr-thangkar-phaethy/cpg/naewthangwech-ptibati-sahrab-rokh-bea-hwan-2567
Nitikarun P, Bunyong R. Coverage of diabetic retinopathy screening and prevalence of diabetic retinopathy in public health regional service provider 6th, Thailand 2016. J Prapokklao Hosp Clin Med Educat Center 2018;35(2):118-27.
Silpa-archa S, Ruamviboonsuk P. Diabetic retinopathy: current treatment and Thailand perspective. J Med Assoc Thai 2017;100 Suppl 1:S136-47.
The Centers for Disease Control and Prevention (CDC), Thailand’s Ministry of Public Health (MOPH). Guidelines for screening, monitoring, and managing diabetes-related eye diseases [internet]. 2015 [cited 11 Aug 2023]. Available from:file:///C:/Users/USER/Downloads/Documents/4.pdf
Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, et al. Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology 2018;125(10):1608-22.
Spurling G, Askew D, Jackson C. Retinopathy--screening recommendations. Aust Fam Physician 2009;38(10):780-3.
Scanlon PH, Aldington SJ, Stratton IM. Short report: complications delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy. Diabet Med 2014;31(1):439-42.
Bresnick G, Cuadros JA, Khan M, Fleischmann S, Wolff G, Limon A, et al. Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting. BMJ Open Diabetes Res Care 2020;8(1):e001154.
Pawaranggoon W. Prevention of diabetic retinopathy in type-2 diabetes patients Nunah Hospital Bangkok. Chiangrai Med J 2017;9(2):73-82.
Bumrungsena K. Prevalence and risk score to predict diabetic retinopathy in diabetic patient, Singhanakorn hospital, Songkla province, Thailand. Weekly Epidemiological Surveillance Report, Thailand 2018;49(38):593-8.
Jindapet E, Jantasiro W, Hajeese W. Factors related to severity of diabetic retinopathy in noninsulin-dependent diabetes mellitus patients in Ra-ngae hospital, Narathiwat Province. J Prachomklao Coll Nurs, Phetchaburi Province 2021;4(2):127-38.
Rodchua A, Viriyasirisakul P, Issaviranont S. Discriminant analysis of factors affecting diabetic retinopathy severity among diabetic patients at Banphaeo Hospital (Public Organization). Christian University J 2022;28(1):15-28.
Vengadesan N, Ahmad M, Sindal MD, Sengupta S. Delayed follow-up in patients with diabetic retinopathy in South India: social factors and impact on disease progression. Indian J Ophthalmol 2017;65(5):376-84.